| HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer (NCT01387932) | Merit Medical Systems, Inc. | 2011-06-01 |
| Association of Conformational High-dose Radiotherapy and of Hyperselective Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma (NCT01300143) | Nantes University Hospital | 2011-06-01 |
| Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular Carcinoma (NCT01377220) | Commissariat A L'energie Atomique | 2011-06-01 |
| Safety and Efficacy of RAD001 + TACE in Localized Unresectable HCC (NCT01379521) | Novartis Pharmaceuticals | 2011-06-01 |
| Hepatocellular Carcinoma (HCC) Transarterial Chemoembolisation (TACE) +Axitinib (NCT01352728) | Chinese University of Hong Kong | 2011-05-18 |
| Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin (NCT01466504) | Dartmouth-Hitchcock Medical Center | 2011-05-01 |
| Evaluation of Cirrhosis and Malignant Hepatic Lesions Using Novel MR Contrast Agents (NCT01341132) | San Francisco Veterans Affairs Medical Center | 2011-05-01 |
| Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma (NCT01348503) | Indiana University | 2011-05-01 |
| Drug-eluting Bead in Hepatocellular Carcinoma (NCT01332669) | Seoul National University Hospital | 2011-04-01 |
| Temsirolimus + Sorafenib in Advanced Hepatocellular Carcinoma (HCC) (NCT01335074) | Philipps University Marburg | 2011-04-01 |
| Effectiveness of Microwave Ablation of Hepatocellular Carcinoma as Compared to Radiofrequency Ablation (NCT01340105) | Chinese University of Hong Kong | 2011-04-01 |
| An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423 (NCT01316679) | Vanderbilt University Medical Center | 2011-03-01 |
| Stiffness Measurement of Liver Tumors and Visceral Parenchyma (NCT01343212) | China Medical University Hospital | 2011-03-01 |
| Radiofrequency Ablation Combined With Transcatheter Arterial Chemoembolization Versus Radiofrequency Ablation Alone for Recurrent Hepatocellular Carcinoma (NCT01415063) | Sun Yat-sen University | 2011-02-01 |
| Study of Axitinib in Patients With Unresectable Hepatocellular Carcinoma (NCT01334112) | University Health Network, Toronto | 2011-01-01 |
| Comparison of Two Solvents Used With Chemotherapy Agent for Transarterial Chemoembolization of Hepatocellular Carcinoma (NCT01259414) | Sun Yat-sen University | 2011-01-01 |
| Observational Study on Patients With Hepatocellular Carcinoma (HCC) (NCT04021056) | Nanfang Hospital, Southern Medical University | 2011-01-01 |
| A Simple Prognostic Scoring System for Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma (NCT02061956) | Sun Yat-sen University | 2011-01-01 |
| Dynamic Contrast-enhanced Magnetic Resonance Imaging in Evaluation of Liver Functional Status and Treatment Efficacy in Patients With Hepatocellular Carcinoma After Locoregional Therapy (NCT01281683) | National Taiwan University Hospital | 2011-01-01 |
| Entecavir for Chronic Hepatitis B in Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation Therapy (NCT01270178) | Taipei Veterans General Hospital, Taiwan | 2011-01-01 |
| Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer (NCT01264705) | University of Texas Southwestern Medical Center | 2011-01-01 |
| Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma (NCT01210495) | Pfizer | 2010-12-06 |
| Orantinib In Combination With Transcatheter Arterial Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma (NCT01465464) | Taiho Pharmaceutical Co., Ltd. | 2010-12-01 |
| PET Scan as a Screening Tool for Liver Transplant in Patients With Hepatocellular Carcinoma (HCC) (NCT01320852) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2010-12-01 |
| Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Primary Hepatocellular Carcinoma (HCC) (NCT01308645) | SBPharmaceutical IND, Co., LTD | 2010-12-01 |
| A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Participants With Hepatocellular Carcinoma After 1st-Line Therapy With Sorafenib (NCT01140347) | Eli Lilly and Company | 2010-10-01 |
| Clinical Study of Sorafenib and Zoledronic Acid to Treat Advanced HCC (NCT01259193) | Fudan University | 2010-10-01 |
| Transcatheter Arterial Chemoembolization Therapy In Combination With Sorafenib (NCT01217034) | Kindai University | 2010-10-01 |
| Study of Combined Sorafenib With Radiotherapy in Patients With Advanced Hepatocellular Carcinoma (NCT01328223) | China Medical University Hospital | 2010-09-01 |
| Risk Factors of Hepatocellular Carcinomas Developed on Non-fibrotic Liver: Case-control Study (NoFlic Study) (NCT03852238) | University Hospital, Bordeaux | 2010-08-18 |
| Hepatocellular Carcinoma - Advanced Stage - Sorafenib Trial in Taiwanese Patients (NCT01098760) | Bayer | 2010-08-01 |
| MRI of the Liver With Eovist (NCT01215838) | University of Washington | 2010-08-01 |
| ABT-888 and Temozolomide for Liver Cancer (NCT01205828) | Georgetown University | 2010-08-01 |
| STA-9090 in Patients With Advanced Hepatocellular Cancer (NCT01665937) | Massachusetts General Hospital | 2010-08-01 |
| Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma (NCT01177397) | Celgene | 2010-07-20 |
| Decrease in Circulating Tumour Cell Count Reflects the Effectiveness of Postoperative Adjuvant Transarterial Chemoembolization (TACE) in Preventing Hepatocellular Carcinoma Recurrence (NCT02032368) | Guangdong Provincial People's Hospital | 2010-07-01 |
| Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (HCC) (NCT01135056) | Singapore General Hospital | 2010-07-01 |
| Changes in Liver Function After Stereotactic Body Radiation Therapy Measured by PET/CT (NCT01213758) | University of Aarhus | 2010-06-01 |
| Combined Radiotherapy and Sorafenib in Patients With Hepatoma (NCT01319942) | China Medical University Hospital | 2010-06-01 |
| Safety Study of Liver Natural Killer Cell Therapy for Hepatoma Liver Transplantation (NCT01147380) | Seigo Nishida | 2010-06-01 |
| Yttrium-90 Radioembolization With Glass Microspheres (TheraSphere) for Patients With Hepatocellular Carcinoma (NCT01290523) | University of California, San Francisco | 2010-05-01 |
| AFP- L3% and DCP as Tumor Markers in Patients With Hepatocellular Carcinoma (HCC) Treated With Transarterial Chemoembolisation (TACE) (NCT01360255) | University Hospital Freiburg | 2010-05-01 |
| Efficacy of Sirolimus In Liver Transplantation for Hepatocellular Carcinoma (HCC) (NCT01374750) | Seoul National University Hospital | 2010-05-01 |
| Primary Cell Culture of Hepatic Tumorous Cells From Routine Fine-needle Aspiration (NCT01549275) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2010-04-01 |
| Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy (NCT01102335) | Fudan University | 2010-04-01 |
| Radiofrequency Ablation Versus Hepatic Resection for the Treatment of Hepatocellular Carcinomas Smaller Than 2 cm (NCT01351194) | Sun Yat-sen University | 2010-03-01 |
| Different Genetic Features Associated With Hepatic Carcinogenesis (NCT01247506) | National Taiwan University Hospital | 2010-02-01 |
| Selective Internal Radiation Therapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Hepatocellular Carcinoma (HCC). (NCT01798160) | Johannes Gutenberg University Mainz | 2010-02-01 |
| Biomarker Analysis in Sorafenib Treated Hepatocellular Carcinoma Patients (NCT01481805) | Samsung Medical Center | 2010-01-14 |
| Sequential Treatment of Hepatocellular Carcinoma by Transarterial Chemoembolization and Local Ablation or External Radiation (NCT04813861) | Central Hospital, Nancy, France | 2010-01-04 |
| Clinical Study Examining the Safety and Efficacy of Doxorubicin Drug Eluting Microspheres Transarterial Embolization in the Setting of Hepatocellular Carcinoma (HCC) (NCT01116635) | University of British Columbia | 2010-01-01 |
| Role of Choline PET/CT in Predicting Survival in Patients With Hepatocellular Carcinoma (NCT03430635) | Humanitas Clinical and Research Center | 2010-01-01 |
| Transcatheter Arterial Chemoembolization Combined With Sorafenib for Unresectable Hepatocellular Carcinoma (NCT01833299) | Sun Yat-sen University | 2010-01-01 |
| Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy (NCT03592706) | Ivy Life Sciences, Co., Ltd | 2009-12-01 |
| Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma (NCT02851784) | Chinese PLA General Hospital | 2009-12-01 |
| A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC) (NCT01451658) | Taipei Veterans General Hospital, Taiwan | 2009-12-01 |
| Prospective Liver Tumor (ProLiT) Database (NCT01607788) | University of Geneva, Switzerland | 2009-11-01 |
| AZD6244 and Sorafenib in Advanced Hepatocellular Carcinoma (NCT01029418) | National Cancer Centre, Singapore | 2009-11-01 |
| Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular Carcinoma (NCT01005875) | University of Alabama at Birmingham | 2009-11-01 |
| Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery (NCT01004978) | National Cancer Institute (NCI) | 2009-10-28 |
| Immunotherapy of Hepatocellular Carcinoma by Induction of Anti-alpha Fetoprotein Response (NCT01128803) | Nantes University Hospital | 2009-10-01 |
| Effects of Telephone Consultations on Discharged Liver Cancer (NCT01595243) | National Taiwan University Hospital | 2009-10-01 |
| Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar Carcinoma (NCT01215565) | Assistance Publique - Hôpitaux de Paris | 2009-10-01 |
| A Study to Assess PV-10 Chemoablation of Cancer of the Liver (NCT00986661) | Provectus Biopharmaceuticals, Inc. | 2009-10-01 |
| Safety Study of Sorafenib Following Combined Therapy of Radiation and TACE for Liver Cancer (NCT00999843) | Fudan University | 2009-10-01 |
| Trial of TG4023 Combined With Flucytosine in Liver Tumors (NCT00978107) | Transgene | 2009-09-01 |
| Trial of S-1 in Combination With Sorafenib for Patients With Advanced Hepatocellular Carcinoma (NCT01131689) | Samsung Medical Center | 2009-09-01 |
| Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer (NCT01042041) | Abramson Cancer Center at Penn Medicine | 2009-09-01 |
| Non-invasive Prediction of Microvascular Invasion in Hepatocellular Carcinoma by Blood-Oxygen-Level Dependent Magnetic Resonance Imaging (BOLD MRI) (NCT00963612) | University Health Network, Toronto | 2009-09-01 |
| Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma) (NCT00976170) | Chugai Pharmaceutical | 2009-09-01 |
| Sorafenib With Capecitabine for Patients With Measurable Hepatocellular Carcinoma (NCT01032850) | New Mexico Cancer Research Alliance | 2009-09-01 |
| A Dose Escalation Trial of Radiation Therapy (RT) for Hepatocellular Carcinoma (HCC) (NCT00960167) | National Taiwan University Hospital | 2009-09-01 |
| Safety and Efficacy of Photodynamic Therapy for Bile Duct Invasion of Hepatocellular Carcinoma (NCT01506115) | Samsung Medical Center | 2009-09-01 |
| Stereotaxic Irradiation of Hepatocellular Carcinoma (NCT01165346) | Centre Oscar Lambret | 2009-08-31 |
| Primary Prevention of Patients With Hepatocellular Carcinoma and Concomitant Esophageal Varices (NCT01970748) | Taipei Veterans General Hospital, Taiwan | 2009-08-01 |
| TACE and Adefovir Compared With Transarterial Chemoembolization (TACE) Alone for Hepatitis B Virus (HBV)-Related Unresectable Hepatocellular Carcinoma (HCC) (NCT00960518) | Tongji University | 2009-08-01 |
| Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC) (NCT00956436) | Biogen | 2009-08-01 |
| Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC (NCT00908752) | Bristol-Myers Squibb | 2009-07-20 |
| Study of Sorafenib In Combination With Low-dose 5-fluorouracil/Cisplatin (FP) Intraarterial Infusion Chemotherapy (NCT00933816) | Kindai University | 2009-07-01 |
| Urea Cream Treatment Sorafenib-Associated HSFR in HCC (NCT01934829) | Chinese Anti-Cancer Association | 2009-07-01 |
| SBRT + TACE for Primary Hepatocellular Carcinoma (NCT00746655) | University of Pittsburgh | 2009-07-01 |
| Study of Sorafenib With Combination of Thalidomide in Hepatocellular Carcinoma (HCC) (NCT00971126) | National Health Research Institutes, Taiwan | 2009-07-01 |
| 4SC-201 (Resminostat) and Sorafenib in Advanced Hepatocellular Carcinoma (NCT00943449) | 4SC AG | 2009-07-01 |
| Analysis of Expression of Specific Markers in Hepatocellular Carcinoma (NCT00858000) | GlaxoSmithKline | 2009-07-01 |
| Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma (NCT00669136) | Lisa H. Butterfield, Ph.D. | 2009-06-01 |
| Trial of Transcatheter Arterial Chemoembolization (TACE) With Sorafenib for Locally Advanced Hepatocellular Carcinoma (HCC) (NCT01170104) | Chung-Ang University | 2009-06-01 |
| Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular Carcinoma (NCT00921531) | Fudan University | 2009-06-01 |
| A Study of IMC-A12 in Combination With Sorafenib in Participants With Advanced Cancer of the Liver (NCT00906373) | Eli Lilly and Company | 2009-05-01 |
| Comparison of Multiphase and Monophasic Arterial Hepatic MRI in the Detection of Arterial Enhancement of CHC Nodules (NCT04687280) | University Hospital, Angers | 2009-04-22 |
| Performance of Imaging for the Diagnosis of Small Hepatocellular Carcinoma (< 3 cm)on Cirrhosis (NCT00848952) | University Hospital, Angers | 2009-03-01 |
| Randomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) (NCT00862082) | Proacta, Incorporated | 2009-03-01 |
| Y-90 Alone or With Sorafenib for Pre-Transplant Hepatocellular Carcinoma (NCT00846131) | Northwestern University | 2009-02-01 |
| A Phase 1-2 Study of CF102 in Patients With Advanced Hepatocellular Carcinoma (NCT00790218) | Can-Fite BioPharma | 2009-02-01 |
| Study of Sorafenib, Gemcitabine, and Cisplatin in Advanced Hepatocellular Carcinoma (HCC) (NCT00808145) | Lahey Clinic | 2009-02-01 |
| Study of Sorafenib and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma (NCT00844883) | Yale University | 2009-02-01 |
| Study in Asia of the Combination of TACE With Sorafenib in HCC Patients (NCT00990860) | Taipei Veterans General Hospital, Taiwan | 2009-02-01 |
| A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere® (NCT00877136) | St. Joseph Hospital of Orange | 2009-02-01 |
| Long-term Follow-up of HALT-C Sustained Virological Responders (NCT00825877) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2009-01-15 |
| Research on Surgery and Micro-Invasive Treatment in Recurrent Primary Liver Cancer (NCT00822562) | Eastern Hepatobiliary Surgery Hospital | 2009-01-01 |
| Total Hemihepatic Vascular Exclusion in Hepatectomy in Hepatocellular Carcinoma Treatment (NCT00827047) | Eastern Hepatobiliary Surgery Hospital | 2009-01-01 |